Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: Possible involvement of the phosphoinositide-3 kinase/Akt pathway

Drug Resistance Updates

Volumn 5, Issue 3-4, 2002, Pages 131-146

  Cheng, Jin Q ^c   Jiang, Xiuxian ^a,b   Fraser, Michael ^a,b   Li, Ming ^a,b   Dan, Han C ^c   Sun, Mei ^c   Tsang, Benjamin K ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chemoresistance; PI3K Akt Ovarian cancer; Xiap

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTINEOPLASTIC AGENT; CISPLATIN; FLICE LIKE INHIBITORY PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANGIOGENESIS; APOPTOSIS; CARCINOMA CELL; CELL CYCLE; CELL SURVIVAL; CLINICAL TRIAL; DOWN REGULATION; DRUG SENSITIVITY; HUMAN; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TREATMENT INDICATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0036619301     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(02)00003-1     Document Type: Review

References (151)

1. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential
2. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
4. Mitrochondrial defects in cisdiamminedichloroplatinum(II)-resistant human ovarian carcinoma cells
5. Options for modulation of drug resistance in ovarian cancer
6. Xiap regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells
7. Ovarian surface epithelium: Biology, endocrinology, and pathology
8. Transducers of life and death: TNF receptor superfamily and associated proteins
9. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
10. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
11. Structure, expression and chromosomal mapping of c-akt: Relationship to v-akt and its implications
12. Cross-linking CD4O on B cells rapidly activates nuclear factor-kappa B
13. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
14. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway
15. Integrin-mediated adhesion and signaling in ovarian cancer cells
16. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
17. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
18. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene
19. AKT2, a putative oncogene encoding a member of a novel subfamily of serine-threonine protein kinases, is amplified in human ovarian carcinomas
20. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
21. Transforming activity and mitosis-dependent expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis
22. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis
23. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
24. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
25. Gene therapy and ovarian cancer: Update of clinical trials
26. Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras?
27. Targeted proteolysis of the focal adhesion kinase pp 125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling
28. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
29. Cellular survival: A play in three Akts
30. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
31. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
32. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
33. X-linked IAP is a direct inhibitor of cell-death proteases
34. IAPs block apoptosis events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
35. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
36. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas
37. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer
38. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
39. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors
40. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2
41. Current treatment for ovarian cancer
42. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
43. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidinositol 3-kinase
44. Disruption of epithelial cell-matrix interactions induces apoptosis
45. Control of adhesion-dependent cell survival by focal adhesion kinase
46. The OSP-1 promoter directs expression of lacZ to the ovaries of transgenic mice
47. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
48. CASH, a novel caspase homologue with death effector domains
49. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
50. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis
51. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
52. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
53. FAK in cultured fibroblasts results in apoptosis
54. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
55. Inhibition of death receptor signals by cellular FLIP
56. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
57. The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis
58. Molecular cloning of a second form of rac protein kinase
59. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
60. Livin, a novel inhibitor of apoptosis protein family member
61. Chemoresistance in ovarian cancer: State of the art and future prospects
62. Apoptosis: Its significance in cancer and cancer therapy
63. The mechanism of cisplatin-resistance in ovarian cancer
64. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules
65. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
66. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor
67. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer
68. p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance
69. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
70. Non-Ras targets of farnesyltransferase inhibitors: Focus on Rho
71. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
72. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
73. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
74. Apoptosis and chemoresistance in human ovarian cancer: Is Xiap a determinant?
75. Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins
76. Kiap, a novel member of the inhibitor of apoptosis protein family
77. Suppression of apoptosis in mammalian cells by Naip and a related family
78. Identification of XAF1 as an antagonist of XIAP anti-caspase activity
79. Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line
80. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells
81. Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells
82. Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line
83. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
84. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
85. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
86. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bβ
87. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3
88. NF-kappaB signals induce the expression of c-FLIP
89. The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy
90. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel
91. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer
92. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway
93. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor ligand system and involves activation of wild-type p53
94. The rise and fall of apoptosis during multistage tumorigenesis: Down-odulation contributes to tumor progression from angiogenic progenitors
95. Identification of a human AKT3 (protein kinase Bγ) which contains the regulatory serine phosphorylation site
96. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
97. Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons
98. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis
99. Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors
100. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors
101. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
102. Bcl-2 and the regulation of programmed cell death
103. The annual report to the nation on the statue of cancer, 1993-1997, with a special section on colorectal cancer
104. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
105. Akt-dependent phosphorylation of p21 (Cip1) regulates PCNA binding and proliferation of endothelial cells
106. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
107. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
108. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinoma
109. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis
110. Life, death and immortality: Cellular and molecular perspectives in human ovarian cancer cell growth
111. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells
112. Caspase-induced, caspase-3-mediated focal adhesion kinase processing in human ovarian cancer cells: Possible regulation by X-linked inhibitor of apoptosis protein
113. Modulation of Akt kinase activity by binding to Hsp9O
114. Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells
115. Inhibition of Ras prenylation: A novel approach to cancer chemotherapy
116. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element
117. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion
118. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2
119. PIK3CA is implicated as an oncogene in ovarian cancer
120. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
121. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis
122. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway
123. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
124. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis
125. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators
126. Intracellular mechanisms of TRAIL: Apoptosis through mitochondrial-dependent and -independent pathways
127. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
128. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K
129. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death
130. A single BIR domain of XIAP sufficient for inhibiting caspases
131. The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro
132. S) prevent apoptosis induced by death receptors
133. Apoptosis in the pathogenesis and treatment of disease
134. Cloning and expression of apoptosis inhibitory protein homologues that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors
135. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-Fas antibody-mediated cytotoxicity and apoptosis
136. Protein kinase B β/Akt2 plays a specific role in muscle differentiation
137. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
138. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
139. Role of NF in gonadotropic regulation of X-linked inhibitor of apoptosis protein (Xiap) expression in rat ovarian granulosa cells in vitro
140. Structural basis of IAP recognition by Smac/DIABLO
141. NFκB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis
142. Autoproteolytic activation of pro-caspases by oligomerization
143. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
144. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
145. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer
146. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
147. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NFκB pathway
148. Akt regulates cell survival and apoptosis at a postmitochondrial level
149. Loss of cis-diamminedichloro-platinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance
150. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis